Taipei, June 27 (CNA) Taiwanese vaccine maker United Biomedical Inc. (UBI) Asia announced Sunday that it will seek emergency use authorization (EUA) in Taiwan for its COVID-19 vaccine candidate before the end of June after unveiling the interim results of its Phase 2 clinical trials.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Mandarin Airlines begins services between Songshan and Matsu's Nangan
03/26/2023 10:45 PM - Society
CECC sees no rise in COVID-19 cases after case reporting ends
03/26/2023 10:26 PM - Cross-Strait
Ma Ying-jeou Foundation blames Tsai's policy failures for Honduras loss
03/26/2023 10:19 PM - Politics
Hondurans in Taiwan reckon with future after diplomatic split
03/26/2023 10:01 PM - Cross-Strait
Different motives seen behind Beijing's poaching of Honduras
03/26/2023 09:24 PM